Abiopharma

Enovis Announces First Quarter 2026 Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest by Director

New Form SCHEDULE 13G/A - IRON MOUNTAIN INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001284812-26-000056 <b>Size:</b> 14 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012426 <b>Size:</b> 984 KB

New Form SCHEDULE 13G/A - SUN COMMUNITIES INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001284812-26-000057 <b>Size:</b> 14 KB

EPAM Systems, Inc. - EPAM Reports Results for First Quarter 2026

Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability

(30% Negative) GENERATE BIOMEDICINES, INC. (GENB) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest by Director

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-GOETZ JAMES J

General Announcement: Mapletree Pan Asia Commercial Trust Investor Presentation - 7 May 2026

KBR’s Mission Technology Solutions Awarded Two Task Orders Supporting US Air Force Operations in Southwest Asia

Claritev Corporation Reports First Quarter 2026 Results

First Advantage Reports First Quarter 2026 Results

Celsius Holdings Reports First Quarter 2026 Financial Results